Adelöw C, Andell E, Amark P. Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: first report from the Stockholm Incidence Registry of Epilepsy (SIRE). Epilepsia. 2009;50(5):1094-1101.
Wirrell EC, Grossardt BR, Wong-Kisiel LC, Nickels KC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 2011;95(1-2):110-118.
Åndell E, Tomson T, Carlsson S. The incidence of unprovoked seizures and occurrence of neurodevelopmental comorbidities in children at the time of their first epileptic seizure and during the subsequent six months. Epilepsy Res. 2015;113:140-150.
Gurcharran K, Grinspan ZM. The burden of pediatric status epilepticus: epidemiology, morbidity, mortality, and costs. Seizure. 2019;68:3-8.
Trinka E, Cock H, Hesdorffer D. A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515-1523.
Hirtz D, Ashwal S, Berg A. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology. 2000;55(5):616-623.
Andrade DM, Berg AT, Hood V. Dravet syndrome: a quick transition guide for the adult neurologist. Epilepsy Res. 2021;177:106743.
Li W, Schneider AL, Scheffer IE. Defining Dravet syndrome: an essential pre-requisite for precision medicine trials. Epilepsia. 2021;62(9):2205-2217.
Christensen KJ, Dreier JW, Skotte L. Birth characteristics and risk of febrile seizures. Acta Neurol Scand. 2021;144(1):51-57.
Vestergaard M, Christensen J. Register-based studies on febrile seizures in Denmark. Brain Dev. 2009;31(5):372-377.
Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics. Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatrics. 2008;121(6):1281-1286.
Subcommittee on Febrile Seizures; American Academy of Pediatrics. Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics. 2011;127(2):389-394.
Patel AD, Vidaurre J. Complex febrile seizures: a practical guide to evaluation and treatment. J Child Neurol. 2013;28(6):762-767.
Camfield P, Camfield C. Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+). Epileptic Disord. 2015;17(2):124-133.
Shinnar S, Berg AT, Moshe SL. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics. 1996;98(2 Pt 1):216-225.
Shinnar S, Berg AT, O’Dell C, Newstein D, Moshe SL, Hauser WA. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol. 2000;48(2):140-147.
Berg AT, Shinnar S, Shapiro ED, Salomon ME, Crain EF, Hauser WA. Risk factors for a first febrile seizure: a matched case-control study. Epilepsia. 1995;36(4):334-341.
Fisher RS, Cross JH, D’Souza C. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58(4):531-542.
Scheffer IE, Berkovic S, Capovilla G. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521.
Fine A, Wirrell EC. Seizures in children. Pediatr Rev. 2020;41(7):321-347.
Sheth RD, Bodensteiner JB. Effective utilization of home-video recordings for the evaluation of paroxysmal events in pediatrics. Clin Pediatr (Phila). 1994;33(10):578-582.
Tatum WO, Hirsch LJ, Gelfand MA. Assessment of the predictive value of outpatient smartphone videos for diagnosis of epileptic seizures. JAMA Neurol. 2020;77(5):593-600.
Loewenberger A, Cope SR, Poole N, Agrawal N. An investigation into the preferred terminology for functional seizures. Epilepsy Behav. 2020;111:107183.
Stone J, Wojcik W, Durrance D. What should we say to patients with symptoms unexplained by disease? The “number needed to offend”. BMJ. 2002;325(7378):1449-1450.
Stone J, Campbell K, Sharma N, Carson A, Warlow CP, Sharpe M. What should we call pseudoseizures? The patient’s perspective. Seizure. 2003;12(8):568-572.
Kerr WT, Janio EA, Le JM. Diagnostic delay in psychogenic seizures and the association with anti-seizure medication trials. Seizure. 2016;40:123-126.
Bahrami Z, Homayoun M, Asadi-Pooya AA. Why is psychogenic nonepileptic seizure diagnosis missed? A retrospective study. Epilepsy Behav. 2019;97:135-137.
Sawchuk T, Asadi-Pooya AA, Myers L. Clinical characteristics of psychogenic nonepileptic seizures across the lifespan: an international retrospective study. Epilepsy Behav. 2020;102:106705.
Duncan AJ, Peric I, Boston R, Seneviratne U. Predictive semiology of psychogenic non-epileptic seizures in an epilepsy monitoring unit. J Neurol. 2022;269(4):2172-2178.
LaFrance WC, Reuber M, Goldstein LH. Management of psychogenic nonepileptic seizures. Epilepsia. 2013;54(Suppl 1):53-67.
Farrar HC, Chande VT, Fitzpatrick DF, Shema SJ. Hyponatremia as the cause of seizures in infants: a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med. 1995;26(1):42-48.
Adams DJ, Lueders H. Hyperventilation and 6-hour EEG recording in evaluation of absence seizures. Neurology. 1981;31(9):1175-1177.
Holmes GL, Frank LM, Sheth RD. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children. Epilepsy Res. 2008;82(2-3):124-132.
- Wirrell EC, Camfield PR, Gordon KE, Camfield CS, Dooley JM, Hanna BD. Will a critical level of hyperventilation-induced hypocapnia always induce an absence seizure? Epilepsia. 1996;37(5):459-462.
Hamiwka L, Singh N, Kozlik S, Wirrell E. Feasibility and clinical utility of early electroencephalogram (EEG) in children with first seizure. J Child Neurol. 2008;23(7):762-765.
- So EL. Interictal epileptiform discharges in persons without a history of seizures: what do they mean? J Clin Neurophysiol. 2010;27(4):229-238.
Borusiak P, Zilbauer M, Jenke AC. Prevalence of epileptiform discharges in healthy children—new data from a prospective study using digital EEG. Epilepsia. 2010;51(7):1185-1188.
Kim HL, Donnelly JH, Tournay AE, Book TM, Filipek P. Absence of seizures despite high prevalence of epileptiform EEG abnormalities in children with autism monitored in a tertiary care center. Epilepsia. 2006;47(2):394-398.
Millichap JJ, Stack CV, Millichap JG. Frequency of epileptiform discharges in the sleep-deprived electroencephalogram in children evaluated for attention-deficit disorders. J Child Neurol. 2011;26(1):6-11.
Kuratani J, Pearl PL, Sullivan L. American Clinical Neurophysiology Society guideline 5: minimum technical standards for pediatric electroencephalography. J Clin Neurophysiol. 2016;33(4):320-323.
Trofimova A, Milla SS, Ryan ME. ACR Appropriateness Criteria® seizures-child. J Am Coll Radiol. 2021;18(5S):S199-S211.
Specchio N, Wirrell EC, Scheffer IE. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1398-1442.
Duffy J, Weintraub E, Hambidge SJ. Febrile seizure risk after vaccination in children 6 to 23 months. Pediatrics. 2016;138(1):e20160320.
Sun Y, Christensen J, Hviid A. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA. 2012;307(8):823-831.
Barlow WE, Davis RL, Glasser JW Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656-661.
Klein NP, Fireman B, Yih WK. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1-e8.
von Spiczak S, Helbig I, Drechsel-Baeuerle U. A retrospective population-based study on seizures related to childhood vaccination. Epilepsia. 2011;52(8):1506-1512.
Tro-Baumann B, von Spiczak S, Lotte J. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome. Epilepsia. 2011;52(1):175-178.
- Centers for Disease Control and Prevention. Vaccine safety: questions and concerns. Febrile seizures and childhood vaccines. https://www.cdc.gov/vaccinesafety/concerns/febrile-seizures.html
Camfield PR, Camfield CS, Dooley JM, Tibbles JA, Fung T, Garner B. Epilepsy after a first unprovoked seizure in childhood. Neurology. 1985;35(11):1657-1660.
Camfield PR, Camfield CS, Smith EC, Tibbles JA. Newly treated childhood epilepsy: a prospective study of recurrences and side effects. Neurology. 1985;35(5):722-725.
Fisher RS, Acevedo C, Arzimanoglou A. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482.
Berg AT, Shinnar S, Hauser WA, Leventhal JM. Predictors of recurrent febrile seizures: a metaanalytic review. J Pediatr. 1990;116(3):329-337.
Berg AT, Shinnar S, Darefsky AS. Predictors of recurrent febrile seizures. A prospective cohort study. Arch Pediatr Adolesc Med. 1997;151(4):371-378.
Berg AT, Shinnar S. Complex febrile seizures. Epilepsia. 1996;37(2):126-133.
Annegers JF, Hauser WA, Shirts SB, Kurland LT. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med. 1987;316(9):493-498.
Gupta A. Febrile seizures. Continuum (Minneap Minn). 2016;22(1 Epilepsy):51-9.
Hesdorffer DC, Shinnar S, Lewis DV. Risk factors for febrile status epilepticus: a case-control study. J Pediatr. 2013;163(4):1147-51.e1.
Patterson KP, Baram TZ, Shinnar S. Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus. Neurotherapeutics. 2014;11(2):242-250.
- Camfield P, Camfield C. Are febrile seizures an indication for intermittent benzodiazepine treatment, and if so, in which cases? Epileptic Disord. 2014;16(Suppl 1):S84-S88.
Fedak Romanowski EM, McNamara NA, Neil EE, Gottlieb-Smith R, Dang LT. Seizure rescue medications for out-of-hospital use in children. J Pediatr. 2021;229:19-25.
Engel ML, Shanley R, Scal PB, Kunin-Batson A. Anxiety and depressive symptoms in adolescents and young adults with epilepsy: the role of illness beliefs and social factors. Epilepsy Behav. 2021;116:107737.
Fisher RS, Cross JH, French JA. Operational classification of seizure types by the International League Against Epilepsy: position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-530.
Carbamazepine. Package insert. Novartis; 2009.
Carpay HA, Arts WF, Geerts AT. Epilepsy in childhood: an audit of clinical practice. Arch Neurol. 1998;55(5):668-673.
Ethosuximide. Package insert. Parke-Davis; 2009.
- Clinical Key. ClinicalPharmacology.com. Valproic acid, divalproex sodium. https://www.clinicalkey.com/pharmacology/monograph/637
Glauser TA, Cnaan A, Shinnar S. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010;362(9):790-799.
Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD. Epilepsy treatment in adults and adolescents: expert opinion, 2016. Epilepsy Behav. 2017;69:186-222.
Tomson T, Marson A, Boon P. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia. 2015;56(7):1006-1019.
Johnson EL, Burke AE, Wang A, Pennell PB. Unintended pregnancy, prenatal care, newborn outcomes, and breastfeeding in women with epilepsy. Neurology. 2018;91(11):e1031-e1039.
Marson AG, Al-Kharusi AM, Alwaidh M. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016-1026.
Marson AG, Al-Kharusi AM, Alwaidh M. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1000-1015.
Prasad A, Kuzniecky RI, Knowlton RC. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol. 2003;60(8):1100-1105.
Lamotrigine. Package insert. GlaxoSmithKline; 2015.
Wong IC, Mawer GE, Sander JW. Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother. 1999;33(10):1037-1042.
Sidhu J, Job S, Singh S, Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006;61(2):191-199.
Levetiracetam. Package insert. UCB, Inc.; 2017.
Oxcabazepine. Package insert. Novartis; 2017.
Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology. 2008;71(19):1527-1534.
Lacosamide. Package insert. UCB, Inc.; 2009.
McMullan J, Sasson C, Pancioli A, Silbergleit R. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010;17(6):575-582.
Berg AT, Nickels K, Wirrell EC. Mortality risks in new-onset childhood epilepsy. Pediatrics. 2013;132(1):124-131.
- Epilepsy Foundation. Seizure first aid training and certification. https://www.epilepsy.com/recognition/first-aid-resources
Abend NS, Bearden D, Helbig I. Status epilepticus and refractory status epilepticus management. Semin Pediatr Neurol. 2014;21(4):263-274.
Sánchez Fernández I, Gaínza-Lein M, Loddenkemper T. Nonintravenous rescue medications for pediatric status epilepticus: a cost-effectiveness analysis. Epilepsia. 2017;58(8):1349-1359.
Wirrell EC. Epilepsy-related injuries. Epilepsia. 2006;47(Suppl 1):79-86.
Nickels KC, Zaccariello MJ, Hamiwka LD, Wirrell EC. Cognitive and neurodevelopmental comorbidities in paediatric epilepsy. Nat Rev Neurol. 2016;12(8):465-476.
Cross JH, Jayakar P, Nordli D. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia. 2006;47(6):952-959.
Wirrell E. Infantile, Childhood, and adolescent epilepsies. Continuum (Minneap Minn). 2016;22(1 Epilepsy):60-93.
Sondhi V, Agarwala A, Pandey RM. Efficacy of ketogenic diet, modified Atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr. 2020;174(10):944-951.
Breu M, Häfele C, Trimmel-Schwahofer P. The relation of etiology based on the 2017 ILAE classification to the effectiveness of the ketogenic diet in drug-resistant epilepsy in childhood. Epilepsia. 2021;62(11):2814-2825.
Morris GL, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):1453-1459.
Kenney D, Jenkins S, Youssef P, Kotagal S. Patient use of complementary and alternative medicines in an outpatient pediatric neurology clinic. Pediatr Neurol. 2016;58:48-52.e7.
Mannel M. Drug interactions with St John’s wort: mechanisms and clinical implications. Drug Saf. 2004;27(11):773-797.
Myers AP, Watson TA, Strock SB. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction. Pharmacotherapy. 2015;35(3):e9-e12.
Sanger TD, Chen D, Fehlings DL. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25(11):1538-1549.
Pearson TS, Pons R. Movement disorders in children. Continuum (Minneap Minn). 2019;25(4):1099-1120.
Singer HS. Tics and Tourette syndrome. Continuum (Minneap Minn). 2019;25(4):936-958.
Dale RC. Tics and Tourette: a clinical, pathophysiological and etiological review. Curr Opin Pediatr. 2017;29(6):665-673.
Robertson MM, Eapen V, Singer HS. Gilles de la Tourette syndrome. Nat Rev Dis Primers. 2017;3:16097.
Hoekstra PJ, Steenhuis MP, Kallenberg CG, Minderaa RB. Association of small life events with self reports of tic severity in pediatric and adult tic disorder patients: a prospective longitudinal study. J Clin Psychiatry. 2004;65(3):426-431.
Lin H, Katsovich L, Ghebremichael M. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry. 2007;48(2):157-166.
Cohrs S, Rasch T, Altmeyer S. Decreased sleep quality and increased sleep related movements in patients with Tourette’s syndrome. J Neurol Neurosurg Psychiatry. 2001;70(2):192-197.
Banaschewski T, Woerner W, Rothenberger A. Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol. 2003;45(10):700-703.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. 5th ed. APA; 2022.
Pringsheim T, Okun MS, Müller-Vahl K. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896-906.
Groth C, Mol Debes N, Rask CU, Lange T, Skov L. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry. 2017;56(4):304-312.
Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: a follow-up study. Ann Neurol. 1987;22(3):383-385.
Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette’s syndrome. Neurology. 2003;61(7):936-940.
Singer HS, Augustine F. Controversies surrounding the pathophysiology of tics. J Child Neurol. 2019;34(13):851-862.
Hirschtritt ME, Darrow SM, Illmann C. Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit/hyperactive subtypes with Tourette syndrome. Psychol Med. 2018;48(2):279-293.
Groth C, Debes NM, Skov L. Phenotype development in adolescents with Tourette syndrome: a large clinical longitudinal study. J Child Neurol. 2017;32(13):1047-1057.
Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet. 1987;41(5):701-741.
Rizzo R, Gulisano M, Calì PV, Curatolo P. Tourette syndrome and comorbid ADHD: current pharmacological treatment options. Eur J Paediatr Neurol. 2013;17(5):421-428.
March JS, Franklin ME, Leonard H. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2007;61(3):344-347.
Conelea CA, Walther MR, Freeman JB. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. J Am Acad Child Adolesc Psychiatry. 2014;53(12):1308-1316.
McGuire JF, Piacentini J, Brennan EA. A meta-analysis of behavior therapy for Tourette syndrome. J Psychiatr Res. 2014;50:106-112.
Osland ST, Steeves TD, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev. 2018(6):CD007990.
Pringsheim T, Holler-Managan Y, Okun MS. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):907-915.
Gilbert DL. Acute and chronic chorea in childhood. Semin Pediatr Neurol. 2009;16(2):71-76.
Teixeira AL, Vasconcelos LP, Nunes MDCP, Singer H. Sydenham’s chorea: from pathophysiology to therapeutics. Expert Rev Neurother. 2021;21(8):913-922.
Ridel KR, Lipps TD, Gilbert DL. The prevalence of neuropsychiatric disorders in Sydenham’s chorea. Pediatr Neurol. 2010;42(4):243-248.
Maia DP, Teixeira AL, Quintão Cunningham MC, Cardoso F. Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology. 2005;64(10):1799-1801.
Orsini A, Foiadelli T, Magistrali M. A nationwide study on Sydenham’s chorea: clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2022;36:1-6.
Elevli M, Celebi A, Tombul T, Gökalp AS. Cardiac involvement in Sydenham’s chorea: clinical and Doppler echocardiographic findings. Acta Paediatr. 1999;88(10):1074-1077.
Fusco C, Spagnoli C. Corticosteroid treatment in Sydenham’s chorea. Eur J Paediatr Neurol. 2018;22(2):327-331.
Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20(5):424-429.
Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34(4):264-269.
Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med. 2010;15(3):157-163.
Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage—mechanisms and management approaches. N Engl J Med. 2013;369(21):2021-2030.
Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol. 1990;17(2):371-379.
Kuban KC, Allred EN, O’Shea M, Paneth N, Pagano M, Leviton A. An algorithm for identifying and classifying cerebral palsy in young children. J Pediatr. 2008;153(4):466-472.
Krägeloh-Mann I, Cans C. Cerebral palsy update. Brain Dev. 2009;31(7):537-544.
Agarwal A, Verma I. Cerebral palsy in children: An overview. J Clin Orthop Trauma. 2012;3(2):77-81.
Monbaliu E, Himmelmann K, Lin JP. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol. 2017;16(9):741-749.
Ozelius LJ, Hewett JW, Page CE. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet. 1997;17(1):40-48.
Ozelius LJ, Bressman SB. Genetic and clinical features of primary torsion dystonia. Neurobiol Dis. 2011;42(2):127-135.
LeDoux MS. The genetics of dystonias. Adv Genet. 2012;79:35-85.
Bressman SB, Sabatti C, Raymond D. The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 2000;54(9):1746-1752.
Jankovic J. Treatment of dystonia. Lancet Neurol. 2006;5(10):864-872.
Roubertie A, Mariani LL, Fernandez-Alvarez E, Doummar D, Roze E. Treatment for dystonia in childhood. Eur J Neurol. 2012;19(10):1292-1299.
Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006;21(5):692-695.
Miyagi Y, Koike Y. Tolerance of early pallidal stimulation in pediatric generalized dystonia. J Neurosurg Pediatr. 2013;12(5):476-482.
Markun LC, Starr PA, Air EL, Marks WJ, Volz MM, Ostrem JL. Shorter disease duration correlates with improved long-term deep brain stimulation outcomes in young-onset DYT1 dystonia. Neurosurgery. 2012;71(2):325-330.
Lohmann K, Klein C. Update on the genetics of dystonia. Curr Neurol Neurosci Rep. 2017;17(3):26.
Wilson RB, Keener AM. Movement disorders in children. Adv Pediatr. 2018;65(1):229-240.
Németh AH. The genetics of primary dystonias and related disorders. Brain. 2002;125(Pt 4):695-721.
Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol. 2003;54(Suppl 6):S18-S24.
Mink JW, Zinner SH. Movement disorders ii: chorea, dystonia, myoclonus, and tremor. Pediatr Rev. 2010;31(7):287-294 , quiz 295.
Uddin MK, Rodnitzky RL. Tremor in children. Semin Pediatr Neurol. 2003;10(1):26-34.
Jakovic J, Madisetty J, Vuong KD. Essential tremor among children. Pediatrics. 2004;114(5):1203-1205.
Brouwers FM, Eisenhofer G, Lenders JW, Pacak K. Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. [viii.]. Endocrinol Metab Clin North Am. 2006;35(4):699-724.
Overby P, Kapklein M, Jacobson RI. Acute ataxia in children. Pediatr Rev. 2019;40(7):332-343.
Fogel BL. Childhood cerebellar ataxia. J Child Neurol. 2012;27(9):1138-1145.
Whelan HT, Verma S, Guo Y. Evaluation of the child with acute ataxia: a systematic review. Pediatr Neurol. 2013;49(1):15-24.
Gieron-Korthals MA, Westberry KR, Emmanuel PJ. Acute childhood ataxia: 10-year experience. J Child Neurol. 1994;9(4):381-384.
Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol. 1994;35(6):673-679.
Caffarelli M, Kimia AA, Torres AR. Acute ataxia in children: a review of the differential diagnosis and evaluation in the emergency department. Pediatr Neurol. 2016;65:14-30.
Thakkar K, Maricich SM, Alper G. Acute Ataxia in childhood: 11-year experience at a major pediatric neurology referral center. J Child Neurol. 2016;31(9):1156-1160.
Maurer VO, Rizzi M, Bianchetti MG, Ramelli GP. Benign neonatal sleep myoclonus: a review of the literature. Pediatrics. 2010;125(4):e919-e924.
Kaddurah AK, Holmes GL. Benign neonatal sleep myoclonus: history and semiology. Pediatr Neurol. 2009;40(5):343-346.
Shuper A, Zalzberg J, Weitz R, Mimouni M. Jitteriness beyond the neonatal period: a benign pattern of movement in infancy. J Child Neurol. 1991;6(3):243-245.
Holmes GL, Russman BS. Shuddering attacks. Evaluation using electroencephalographic frequency modulation radiotelemetry and videotape monitoring. Am J Dis Child. 1986;140(1):72-73.
Kanazawa O. Shuddering attacks-report of four children. Pediatr Neurol. 2000;23(5):421-424.
Mahone EM, Bridges D, Prahme C, Singer HS. Repetitive arm and hand movements (complex motor stereotypies) in children. J Pediatr. 2004;145(3):391-395.
Governale LS. Craniosynostosis. Pediatr Neurol. 2015;53(5):394-401.
Sanchez-Lara PA, Carmichael SL, Graham JM. Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A. 2010;152A(2):394-400.
Carmichael SL, Ma C, Rasmussen SA, Honein MA, Lammer EJ, Shaw GM. Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol. 2008;82(2):78-85.
Rasmussen SA, Yazdy MM, Carmichael SL, Jamieson DJ, Canfield MA, Honein MA. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol. 2007;110(2 Pt 1):369-377.
Kimonis V, Gold JA, Hoffman TL, Panchal J, Boyadjiev SA. Genetics of craniosynostosis. Semin Pediatr Neurol. 2007;14(3):150-161.
Dias MS, Samson T, Rizk EB, Governale LS, Richtsmeier JT. Identifying the misshapen head: craniosynostosis and related disorders. Pediatrics. 2020;146(3):e2020015511.
Kattwinkel J, Brooks J, Keenan ME, Malloy M. Infant sleep position and sudden infant death syndrome (SIDS) in the United States: joint commentary from the American Academy of Pediatrics and selected agencies of the federal government. Pediatrics. 1994;93(5):820.
Turk AE, McCarthy JG, Thorne CH, Wisoff JH. The “back to sleep campaign” and deformational plagiocephaly: is there cause for concern?. J Craniofac Surg. 1996;7(1):12-18.
Goh JL, Bauer DF, Durham SR, Stotland MA. Orthotic (helmet) therapy in the treatment of plagiocephaly. Neurosurg Focus. 2013;35(4):E2.
Mortenson P, Steinbok P, Smith D. Deformational plagiocephaly and orthotic treatment: indications and limitations. Childs Nerv Syst. 2012;28(9):1407-1412.
Xia JJ, Kennedy KA, Teichgraeber JF, Wu KQ, Baumgartner JB, Gateno J. Nonsurgical treatment of deformational plagiocephaly: a systematic review. Arch Pediatr Adolesc Med. 2008;162(8):719-727.
Grummer-Strawn LM, Reinold C, Krebs NF. Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep. 2010;59(RR-9):1-15.
Nellhaus G. Head circumference from birth to eighteen years. Practical composite international and interracial graphs. Pediatrics. 1968;41(1):106-114.
Pattisapu JV, Gegg CA, Olavarria G, Johnson KK, Ruiz RL, Costello BJ. Craniosynostosis: diagnosis and surgical management. Atlas Oral Maxillofac Surg Clin North Am. 2010;18(2):77-91.
Badve CAKMM, Iyer RS, Ishak GE, Khanna PC. Craniosynostosis: imaging review and primer on computed tomography. Pediatr Radiol. 2013;43(6):728-742 , quiz 725-727.
Kim HJ, Roh HG, Lee IW. Craniosynostosis: updates in radiologic diagnosis. J Korean Neurosurg Soc. 2016;59(3):219-226.
Starr JR, Collett BR, Gaither R. Multicenter study of neurodevelopment in 3-year-old children with and without single-suture craniosynostosis. Arch Pediatr Adolesc Med. 2012;166(6):536-542.
Speltz ML, Collett BR, Wallace ER. Intellectual and academic functioning of school-age children with single-suture craniosynostosis. Pediatrics. 2015;135(3):e615-e623.
Ashwal S, Michelson D, Plawner L, Dobyns WB. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2009;73(11):887-897.
Cragan JD, Isenburg JL, Parker SE. Population-based microcephaly surveillance in the United States, 2009 to 2013: An analysis of potential sources of variation. Birth Defects Res A Clin Mol Teratol. 2016;106(11):972-982.
Abuelo D. Microcephaly syndromes. Semin Pediatr Neurol. 2007;14(3):118-127.
von der Hagen M, Pivarcsi M, Liebe J. Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev Med Child Neurol. 2014;56(8):732-741.
de Vries LS. Viral infections and the neonatal brain. Semin Pediatr Neurol. 2019;32:100769.
Hanzlik E, Gigante J. Microcephaly. Children (Basel). 2017;4(6):47.
McAuley JB. Congenital toxoplasmosis. J Pediatric Infect Dis Soc. 2014;3(Suppl 1):S30-S35.
Gordon-Lipkin E, Gentner MB, German R, Leppert ML. Neurodevelopmental outcomes in 22 children with microcephaly of different etiologies. J Child Neurol. 2017;32(9):804-809.
Abdel-Salam GM, Halász AA, Czeizel AE. Association of epilepsy with different groups of microcephaly. Dev Med Child Neurol. 2000;42(11):760-767.
Bryant JP, Hernandez NE, Niazi TN. Macrocephaly in the primary care provider’s office. Pediatr Clin North Am. 2021;68(4):759-773.
Muenchberger H, Assaad N, Joy P, Brunsdon R, Shores EA. Idiopathic macrocephaly in the infant: long-term neurological and neuropsychological outcome. Childs Nerv Syst. 2006;22(10):1242-1248.
Accogli A, Geraldo AF, Piccolo G. Diagnostic Approach to Macrocephaly in Children. Front Pediatr. 2022;9:794069.
Weaver DD, Christian JC. Familial variation of head size and adjustment for parental head circumference. J Pediatr. 1980;96(6):990-994.
Bushby KM, Cole T, Matthews JN, Goodship JA. Centiles for adult head circumference. Arch Dis Child. 1992;67(10):1286-1287.
Haws ME, Linscott L, Thomas C, Orscheln E, Radhakrishnan R, Kline-Fath B. A retrospective analysis of the utility of head computed tomography and/or magnetic resonance imaging in the management of benign macrocrania. J Pediatr. 2017;182:283-289.e1.
Sampson MA, Berg AD, Huber JN, Olgun G. Necessity of intracranial imaging in infants and children with macrocephaly. Pediatr Neurol. 2019;93:21-26.
Zahl SM, Egge A, Helseth E, Wester K. Benign external hydrocephalus: a review, with emphasis on management. Neurosurg Rev. 2011;34(4):417-432.
Wright Z, Larrew TW, Eskandari R. Pediatric hydrocephalus: current state of diagnosis and treatment. Pediatr Rev. 2016;37(11):478-490.
Isaacs AM, Riva-Cambrin J, Yavin D. Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS One. 2018;13(10):e0204926.
Patel SK, Tari R, Mangano FT. Pediatric hydrocephalus and the primary care provider. Pediatr Clin North Am. 2021;68(4):793-809.
Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, Kestle JR. Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr. 2008;1(2):131-137.
Tully HM, Dobyns WB. Infantile hydrocephalus: a review of epidemiology, classification and causes. Eur J Med Genet. 2014;57(8):359-368.
Kalyvas AV, Kalamatianos T, Pantazi M, Lianos GD, Stranjalis G, Alexiou GA. Maternal environmental risk factors for congenital hydrocephalus: a systematic review. Neurosurg Focus. 2016;41(5):E3.
Wood JR, Pedersen RC, Rooks VJ. Neuroimaging for the primary care provider: a review of modalities, indications, and pitfalls. Pediatr Clin North Am. 2021;68(4):715-725.
Stoquart-El Sankari S, Lehmann P, Gondry-Jouet C. Phase-contrast MR imaging support for the diagnosis of aqueductal stenosis. AJNR Am J Neuroradiol. 2009;30(1):209-214.
O’Neill BR, Pruthi S, Bains H. Rapid sequence magnetic resonance imaging in the assessment of children with hydrocephalus. World Neurosurg. 2013;80(6):e307-e312.
Kulkarni AV, Riva-Cambrin J, Rozzelle CJ. Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus: a prospective study by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr. 2018;21(3):214-223.
Shastin D, Zaben M, Leach P. Life with a cerebrospinal fluid (CSF) shunt. BMJ. 2016;355:i5209.
